Search research articles
Contact Us
Filters
Showing results (11-20 of 201) with videos related to
Page
of 21
Sort By:
Der Nervenarzt
|
August 24, 2021
[Immunotherapy and personalized treatment of multiple sclerosis]
Ralf A Linker, Ralf Gold
Expert Opinion on Therapeutic Targets
|
April 13, 2012
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
De-Hyung Lee, Ralf A Linker
Experimental & Translational Stroke Medicine
|
February 10, 2010
Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
Ralf A Linker, De-Hyung Lee
Therapeutic Advances in Neurological Disorders
|
December 25, 2010
Innovative monoclonal antibody therapies in multiple sclerosis
Ralf A Linker, Bernd C Kieseier
Journal of the Neurological Sciences
|
June 14, 2005
Mechanisms of axonal degeneration in EAE--lessons from CNTF and MHC I knockout mice
Ralf A Linker, Michael Sendtner, Ralf Gold
Expert Review of Neurotherapeutics
|
September 23, 2009
Plasmapheresis for neurological disorders
Alexandra Schröder, Ralf A Linker, Ralf Gold
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 31, 2013
Advancing therapeutic options in multiple sclerosis with neuroprotective properties
Anke Stroet, Ralf A Linker, Ralf Gold
Pflugers Archiv : European Journal of Physiology
|
February 13, 2017
Macrophages in neuroinflammation: role of the renin-angiotensin-system
Anna Hammer, Johannes Stegbauer, Ralf A Linker
Neural Regeneration Research
|
November 26, 2015
The choline pathway as a strategy to promote central nervous system (CNS) remyelination
Thomas Skripuletz, Ralf A Linker, Martin Stangel
International Journal of Molecular Sciences
|
October 31, 2012
Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters
De-Hyung Lee, Ralf Gold, Ralf A Linker
Page
of 21
Search research articles
Search
Showing results (11-20 of 201) with videos related to
Sort By:
Page
of 21
Der Nervenarzt
|
August 24, 2021
[Immunotherapy and personalized treatment of multiple sclerosis]
Ralf A Linker, Ralf Gold
Expert Opinion on Therapeutic Targets
|
April 13, 2012
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
De-Hyung Lee, Ralf A Linker
Experimental & Translational Stroke Medicine
|
February 10, 2010
Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
Ralf A Linker, De-Hyung Lee
Therapeutic Advances in Neurological Disorders
|
December 25, 2010
Innovative monoclonal antibody therapies in multiple sclerosis
Ralf A Linker, Bernd C Kieseier
Journal of the Neurological Sciences
|
June 14, 2005
Mechanisms of axonal degeneration in EAE--lessons from CNTF and MHC I knockout mice
Ralf A Linker, Michael Sendtner, Ralf Gold
Expert Review of Neurotherapeutics
|
September 23, 2009
Plasmapheresis for neurological disorders
Alexandra Schröder, Ralf A Linker, Ralf Gold
Journal of Neural Transmission (Vienna, Austria : 1996)
|
May 31, 2013
Advancing therapeutic options in multiple sclerosis with neuroprotective properties
Anke Stroet, Ralf A Linker, Ralf Gold
Pflugers Archiv : European Journal of Physiology
|
February 13, 2017
Macrophages in neuroinflammation: role of the renin-angiotensin-system
Anna Hammer, Johannes Stegbauer, Ralf A Linker
Neural Regeneration Research
|
November 26, 2015
The choline pathway as a strategy to promote central nervous system (CNS) remyelination
Thomas Skripuletz, Ralf A Linker, Martin Stangel
International Journal of Molecular Sciences
|
October 31, 2012
Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters
De-Hyung Lee, Ralf Gold, Ralf A Linker
Page
of 21